Compound Tirzepatide Injections Serving all of Florida

Weight-Loss With Tirzepatide

Get Started Or Call 727-456-8686
Vial of Tirzepatide for weight loss injections

60mg Vial Of Compound Tirzepatide $899

No hidden fees – No insurance needed!

Our personalized Tirzepatide program includes:

  • 60mg (300 units) Vial of compound Tirzepatide
  • Syringes and Alcohol Wipes
  • Weekly Check-in’s Via Text Message
  • Exercise Plan
  • Nutrition Guide

*Ask about our in-office shots (1-45 units $100) & (50 + units $125).

**We can only prescribe if you live in the state of Florida.**

Get A Free Consultation Today

Now Offering Afterpay

Offering Afterpay for in-office purchases of the 12 week program. Choose Afterpay when you checkout in our office so you can pay it in 4 interest-free installments. Click on the Afterpay picture for details and/or to sign up.    

picture of Afterpay icon

Tirzepatide For Weight Loss

Compound Tirzepatide is a powerful prescription weight loss once a week injection that suppresses your appetite. Compound Tirzepatide This weight loss medication is for those who are serious about losing a significant amount of weight in a short period of time. If you feel weight loss injections are for you, contact us at Invigorate Wellness Medical of Trinity to schedule a consultation.

How Does Compound Tirzepatide Work?

Compound Tirzepatide works by mimicking two key hormones involved in regulating metabolism: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These hormones help increase insulin production, decrease glucagon secretion, and slow gastric emptying, which collectively contribute to better blood sugar control and a reduction in appetite.

Doctor for Invigorate Wellness

How Can Compound Tirzepatide Help You?

  • Weight-Loss.
  • Reduces food intake by reducing appetite.
  • It slows food digestion in the stomach.
  • Decrease body fat percentage.
  • It can help suppress food cravings and keep you on track to lose weight.
  • Decreased cardiovascular outcomes in subjects with type 2 diabetes and cardiovascular disease.
Get Started